Synectics PLC - Sheffield, England-based provider of advanced security and surveillance systems solutions - Wins contracts totalling USD2.7 million. The four pacts are with gaming sector partners.
(Alliance News) - The UK prime minister insisted he was sticking to his missions as he set out "ambitious" targets for Whitehall, despite claims he was "watering down" promises. In a speech at ...
The firm referred to full-year market expectations of GBP70.45 million for revenue, GBP10 million for adjusted operating profit and GBP8.4 million for adjusted profit before tax. These compare with ...
The London-based packaging company labelled its performance as "solid", but pretax profit plunged 89% on-year to GBP29 million in the six months that ended October 31. Revenue fell 4.2% to GBP3.37 ...
The Kent, England-based agriculture and engineering services firm has sold its entire 37% stake in BF&M to Bermuda Life Insurance Co Ltd, a subsidiary of Argus Group Holdings Ltd, for USD100.0 million ...
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: ...
Bloomberg sources that London-based Aviva has made a fresh bid of about 261 pence per share as it seeks to secure the backing of Direct Line’s board. The new proposal is about 4% higher than Aviva’s ...
By contrast, the two largest drags on interim performance were Diageo PLC and Pernod Ricard SA, which, according to STS, "have each suffered from a similar malaise as they work through the aftermath ...
Shares in Trakm8 were down 30% at 4.00 pence each in London on Thursday afternoon. Revenue fell 2.4% to GBP8.3 million from GBP8.5 million last year, while total administrative costs increased 14% to ...
(Alliance News) - Grit Real Estate Income Group Ltd on Thursday said it has entered a strategic partnership with Broll Property Group Pty Ltd, as part of Grit's ongoing efforts to optimise its ...
(Alliance News) - Amcomri Group PLC on Thursday said it expects to be admitted to London's Alternative Investment Market on December 19.
(Alliance News) - AstraZeneca PLC on Thursday said the US Food & Drug Administration has approved its Imfinzi treatment for adults with limited-stage small cell lung cancer.